How would you manage an single infield mediastinal lymph node recurrence in a patient who has undergone preoperative chemoradiation to 50.4 Gy for gastroesophageal adenocarcinoma followed by esophagectomy and is progressing on immunotherapy?
Answer from: Radiation Oncologist at Academic Institution
Hard question – many variables (and answers). I think the timing of recurrence and overlap/proximity to central structures (and extent of overlap to prior RT) biggest determinants of fractionation and whether to offer RT at this junction (i.e., if ‘ultra-central’ location, would ce...
Comments
Radiation Oncologist at Munson Medical Center Dr. @Atkins brings up all the relevant consid...
Radiation Oncologist at Fox Chase Cancer Center I agree with Dr. @Atkins Atkins and Dr. @Forster. ...
Radiation Oncologist at University of Nebraska Medical Center Great discussion. I don't usually re-irradiate the...
Dr. @Atkins brings up all the relevant consid...
I agree with Dr. @Atkins Atkins and Dr. @Forster. ...
Great discussion. I don't usually re-irradiate the...